Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy
Pharmacological Research · 2025
DOI: 10.1016/j.phrs.2024.107553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2025. Verfasst von Cong Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research…. Hauptthemen laut MEDLINE: Sesquiterpenes, Neoplasms, Lactones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Regulated cell death (RCD) is a type of cell death modulated by specific signal transduction pathways. Currently, known RCD types include apoptosis, autophagy, ferroptosis, necroptosis, cuproptosis, pyroptosis, and NETosis. Mutations in cancer cells may prevent the RCD pathway; therefore, targeting RCD in tumors has become a promising therapeutic approach. Sesquiterpene lactones represent a diverse and extensive class of plant-derived phytochemicals that serve as potential sources for developing various drugs. Recent studies have shown that sesquiterpene lactones have promising potential in cancer treatment. This review systematically summarizes recent progress in the study of sesquiterpene lactones as antitumor agents, highlighting their role in targeting various RCD pathways, including those involved in apoptosis, autophagy, ferroptosis, necroptosis, and cuproptosis. The primary purpose of the present review is to provide a clear picture of the regulation of RCD by sesquiterpene lactones against different targets in various cancers, which will facilitate the development of new strategies for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210000, China; State Key Laboratory of Quality Research in C…
- Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210000, China.
- Department of Vascular and Tumor Interventional Medicine, Affiliated Hospital of Jining Medical University, Jining 272000, China.
- Cancer Center, Faculty of Health Science, University of Macau, 999078, Macao.
- State Key Laboratory of Quality Research in Chinese Medicines and Faculty of Chinese Medicine, Macau University of Science and Technology, 999078, Macao. Electronic address: qbwu@must.edu.mo.
- Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210000, China; DongTai People's Hospital, Dongtai, Jiangsu,…
Zitieren
APA
Xu, C., Wen, S., Du, X., Zou, X., Leung, E. L., Zhou, G., Wu, Q., & Shen, B. (2025). Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy. Pharmacological Research. https://doi.org/10.1016/j.phrs.2024.107553
Vancouver
Xu C, Wen S, Du X, Zou X, Leung EL, Zhou G, et al. Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy. Pharmacological Research. 2025. doi:10.1016/j.phrs.2024.107553
BibTeX
@article{Xu2025,
author = {Xu, Cong and Wen, Shaodi and Du, Xiaoyue and Zou, Xinhua and Leung, Elaine Lai-Han and Zhou, Guoren and Wu, Qibiao and Shen, Bo},
title = {Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy},
journal = {Pharmacological Research},
year = {2025},
doi = {10.1016/j.phrs.2024.107553}
}
EUVIMED